Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
alternative routes have unknown safety implications Efficacy : The dose-response relationship established in trials assumes subcutaneous delivery Tolerability : Gastrointestinal adverse effects (nausea, vomiting, diarrhea) are dose-dependent and may be affected by altered absorption Patients with lower body mass index or those injecting in areas with less subcutaneous fat may be at higher risk of inadvertent intramuscular injection if proper technique is not followed
Rodent models with induced ovarian damage or uterine injury treated with GHK-Cu demonstrate more rapid tissue repair, thicker, more vascularized endometrium, and in some instances improved litter sizes relative to untreated controls
Diabetes Healthc
Join 675+ users tracking their GLP-1 journey with data-backed pharmacokinetic tools
Users with diagnosed IBS report better outcomes than those using it for general health, and some report no difference after a full month at the standard dose
